167 related articles for article (PubMed ID: 25545671)
1. Juvenile slow progressive antineutrophil cytoplasmic antibody-associated vasculitis diagnosed after kidney transplantation: a case report.
Hasegawa J; Wakai S; Shirakawa H
Ther Apher Dial; 2015 Jun; 19(3):303-4. PubMed ID: 25545671
[No Abstract] [Full Text] [Related]
2. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
Apaydin S
Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
[TBL] [Abstract][Full Text] [Related]
3. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
4. Double Filtration Plasmapheresis in the Treatment of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis With Severe Renal Failure: A Preliminary Study of 15 Patients.
Chen Y; Yang L; Li K; Liu Z; Gong D; Zhang H; Liu Z; Hu W
Ther Apher Dial; 2016 Apr; 20(2):183-8. PubMed ID: 26948291
[TBL] [Abstract][Full Text] [Related]
5. Increase of Antimyeloperoxidase Antineutrophil Cytoplasmic Antibody (ANCA) in Patients with Renal ANCA-associated Vasculitis: Association with Risk to Relapse.
Yamaguchi M; Ando M; Kato S; Katsuno T; Kato N; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
J Rheumatol; 2015 Oct; 42(10):1853-60. PubMed ID: 26373560
[TBL] [Abstract][Full Text] [Related]
6. MPO-ANCA Vasculitis Pachymeningitis with Bilateral Vision Loss.
Cho J; Carabenciov I; Wieland M
Minn Med; 2015 Aug; 98(8):41. PubMed ID: 26455039
[No Abstract] [Full Text] [Related]
7. Plasmapheresis in diffuse alveolar hemorrhage as perinuclear antineutrophil cytoplasmic antibody-associated vasculitis relapse on hemodialysis.
Cigarrán S; Castro MJ; Pousa M; Paredes S; Bernardo H; Porteiro M
Ther Apher Dial; 2010 Jun; 14(3):368-72. PubMed ID: 20609194
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis.
Walsh M
Curr Opin Nephrol Hypertens; 2014 Nov; 23(6):555-9. PubMed ID: 25144513
[TBL] [Abstract][Full Text] [Related]
9. Role of therapeutic plasmapheresis in ANCA-associated vasculitis.
Walters G
Pediatr Nephrol; 2016 Feb; 31(2):217-25. PubMed ID: 25986911
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
Shuai ZW; Lv YF; Zhang MM; Hu ZY
Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
[TBL] [Abstract][Full Text] [Related]
11. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
[No Abstract] [Full Text] [Related]
12. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations.
Charles Jennette J; Falk RJ
Presse Med; 2013 Apr; 42(4 Pt 2):493-8. PubMed ID: 23465301
[No Abstract] [Full Text] [Related]
13. Clinical presentation and outcome of pediatric ANCA-associated glomerulonephritis.
Kouri AM; Andreoli SP
Pediatr Nephrol; 2017 Mar; 32(3):449-455. PubMed ID: 27677979
[TBL] [Abstract][Full Text] [Related]
14. Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer.
Hosoya Y; Minota S; Lefor A; Sakuma K; Aoki Y; Kamimura T; Niwa Y; Kajii E; Kanai N; Yasuda Y
Mod Rheumatol; 2010 Feb; 20(1):102-5. PubMed ID: 19802649
[TBL] [Abstract][Full Text] [Related]
15. What are the benefits and harms of anti-cytokine targeted therapies for adults with anti-neutrophil cytoplasmic antibody-associated vasculitis? - A Cochrane Review summary with commentary.
Coskun Benlidayi I
Int J Rheum Dis; 2021 May; 24(5):724-727. PubMed ID: 33835676
[No Abstract] [Full Text] [Related]
16. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
de Joode AA; Sanders JS; Smid WM; Stegeman CA
J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
[TBL] [Abstract][Full Text] [Related]
17. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis].
Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW
Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334
[No Abstract] [Full Text] [Related]
18. Complete remission of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated crescentic glomerulonephritis complicated with rheumatoid arthritis using a humanized anti-interleukin 6 receptor antibody.
Sumida K; Ubara Y; Suwabe T; Hayami N; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Sawa N; Takemoto F; Takaichi K; Ohashi K
Rheumatology (Oxford); 2011 Oct; 50(10):1928-30. PubMed ID: 21719417
[No Abstract] [Full Text] [Related]
19. Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.
Górka J; Polok K; Nowak I; Włudarczyk A; Sydor W; Padjas A; Sznajd J; Szczeklik W; Musiał J
Przegl Lek; 2016; 73(7):445-7. PubMed ID: 29676884
[TBL] [Abstract][Full Text] [Related]
20. [PEXIVAS-The kiss of death for plasma exchange in ANCA-associated vasculitis?].
Löffler C; Hellmich B
Z Rheumatol; 2020 Nov; 79(9):910-911. PubMed ID: 33025026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
